Table 2.
Baseline demographics of subjects who withdrew from ITT population before completing REFLECT-1
| Placebo (n = 28) | 2 mg RSG XR (n = 27) | 8 mg RSG XR (n = 29) | 10 mg donepezil (n = 21) | |
|---|---|---|---|---|
| Age, years | ||||
| Mean ± SD | 74.8±8.08 | 71.5±7.14 | 75.2±7.86 | 75.2±7.86 |
| Range | 55–88 | 57–85 | 54–91 | 58–84 |
| Sex (female:male), % | 54:46 | 67:33 | 59:41 | 76:24 |
| Ethnicity – Hispanic or Latino (yes:no), % | 14:86 | 11:89 | 10:90 | 14:86 |
| Body mass index | ||||
| Mean ± SD | 24.6±4.14 | 24.8±4.52 | 24.2±3.86 | 25.1±3.86 |
| Range | 17–33 | 17–33 | 14–31 | 17–33 |
| MMSE score | 19.8±3.95 | 18.1±4.15 | 18.5±4.21 | 19.0±4.44 |